Identification of a protein expression signature distinguishing early from organising diffuse alveolar damage in COVID-19 patients.
COVID-19
INFLAMMATION
Immune System Diseases
LUNG
Journal
Journal of clinical pathology
ISSN: 1472-4146
Titre abrégé: J Clin Pathol
Pays: England
ID NLM: 0376601
Informations de publication
Date de publication:
Aug 2023
Aug 2023
Historique:
received:
10
01
2023
accepted:
09
02
2023
medline:
21
7
2023
pubmed:
10
3
2023
entrez:
9
3
2023
Statut:
ppublish
Résumé
Diffuse alveolar damage (DAD) is the histological expression of acute respiratory distress syndrome and characterises lung pathology due to infection with SARS-CoV-2, and other respiratory pathogens of clinical significance. DAD reflects a time-dependent immunopathological process, progressing from an early/exudative stage through to an organising/fibrotic stage, yet within an individual these different stages of DAD may coexist. Understanding the progression of DAD is central to the development of new therapeutics to limit progressive lung damage. Here, we applied highly multiplexed spatial protein profiling to autopsy lung tissues derived from 27 patients who died from COVID-19 and identified a protein signature (ARG1, CD127, GZMB, IDO1, Ki67, phospho-PRAS40 (T246) and VISTA) that distinguishes early DAD from late DAD with good predictive accuracy. These proteins warrant further investigation as potential regulators of DAD progression.
Identifiants
pubmed: 36894313
pii: jcp-2023-208771
doi: 10.1136/jcp-2023-208771
pmc: PMC10423525
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
561-565Subventions
Organisme : Wellcome Trust
Pays : United Kingdom
Informations de copyright
© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
Histopathology. 2021 Mar;78(4):542-555
pubmed: 32926596
Cell. 2012 Apr 13;149(2):274-93
pubmed: 22500797
J Pathol. 2022 Mar;256(3):256-261
pubmed: 34859884
Virchows Arch. 2004 Oct;445(4):375-81
pubmed: 15480769
Respir Res. 2022 Sep 12;23(1):242
pubmed: 36096801
J Pathol. 2021 Jan;253(1):31-40
pubmed: 32930394
Bioinformatics. 2005 Oct 15;21(20):3940-1
pubmed: 16096348
Nat Commun. 2020 Oct 8;11(1):5086
pubmed: 33033248
Nature. 2021 Jul;595(7865):107-113
pubmed: 33915569
Mod Pathol. 2021 Aug;34(8):1444-1455
pubmed: 33883694
Lancet Respir Med. 2022 Jan;10(1):95-106
pubmed: 34871544
J Exp Med. 2022 Feb 7;219(2):
pubmed: 35015026
Front Immunol. 2021 Feb 11;11:595950
pubmed: 33643285
Front Immunol. 2021 Jul 14;12:695972
pubmed: 34341659
Nature. 2021 May;593(7860):564-569
pubmed: 33780969
Tohoku J Exp Med. 2014;234(1):67-75
pubmed: 25186104